EAM
CELG

Eclectica Asset Management’s Celgene Corp CELG Stock Holding History

Eclectica Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-9,800
Closed -$842K – 57
2014
Q2 		$842K Buy
+9,800
New +$745K 0.84% 34

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Eclectica Asset Management's CELG Position: Q3 2014 in Review

Eclectica Asset Management sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 9,800 shares — an estimated $842K sold.

Eclectica Asset Management first reported a position in CELG in Q2 2014 and held it in 1 quarter. The position peaked at $842K in Q2 2014. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • Eclectica Asset Management reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
  • Eclectica Asset Management sold 9,800 Celgene Corp shares in Q3 2014, an estimated $842K.
  • Eclectica Asset Management first reported a position in Celgene Corp in Q2 2014 and held it in 1 quarter.
  • Eclectica Asset Management's Celgene Corp position peaked at $842K in Q2 2014.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Eclectica Asset Management's 13F filing for Q3 2014, filed 12 Nov 2014.